[Form 4] Roivant Sciences Ltd. Insider Trading Activity

Rhea-AI Filing Summary

Richard Pulik, identified as CFO and a director of Roivant Sciences Ltd. (ROIV), reported a disposition of 2,340 common shares on 08/28/2025 at a price of $11.94 per share. The filing states this sale represents a net settlement by the issuer to satisfy tax withholding obligations related to previously granted restricted stock units (RSUs). Following the reported transaction, Mr. Pulik beneficially owned 393,978 shares. The Form 4 was signed by an attorney-in-fact on 09/02/2025.

Insights

Financial Analyst

TL;DR: A routine insider net-settlement of RSUs by the CFO to cover taxes, not an open-market sell-off; limited investor impact.

The reported disposition of 2,340 shares at $11.94 is described explicitly as a net settlement to satisfy tax withholding on RSU vesting. Because the shares were surrendered to the issuer rather than sold in the open market, the transaction is less likely to signal a change in the CFO's view of company prospects. The remaining beneficial ownership of 393,978 shares provides context on continued insider exposure.

Corporate Governance Expert

TL;DR: Disclosure is standard and compliant; transaction type and signature by attorney-in-fact are properly documented.

The Form 4 lists the reporting person, role (CFO and director), transaction date, code, and an explanatory note that the disposition was a net settlement for tax withholding, which aligns with common RSU settlement practices. The filing was executed by an attorney-in-fact and includes the required explanatory legend. From a governance perspective, the form contains the expected details and does not raise compliance concerns based on the disclosed information.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pulik Richard

(Last) (First) (Middle)

C/O ROIVANT SCIENCES LTD.

7TH FLOOR, 50 BROADWAY

(Street)

LONDON X0 SW1H 0DB

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Roivant Sciences Ltd. [ ROIV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

3. Date of Earliest Transaction (Month/Day/Year)
08/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	08/28/2025		F		2,340(1)	D	$11.94	393,978	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.

	By: /s/ Jo Chen, as Attorney-in-Fact for Richard Pulik	09/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Roivant (ROIV) CFO Richard Pulik report on Form 4?

The Form 4 reports a disposition of 2,340 common shares on 08/28/2025 at $11.94 per share, described as a net settlement for tax withholding.

Why were the 2,340 shares disposed of according to the filing?

The filing states the shares were surrendered in a net settlement by the issuer to satisfy applicable tax withholding obligations related to RSU vesting.

How many shares does Richard Pulik beneficially own after the transaction?

Following the reported transaction, the filing shows 393,978 shares beneficially owned.

When was the Form 4 signed and who signed it?

The Form 4 was signed on 09/02/2025 by Jo Chen as attorney-in-fact for Richard Pulik.

Does the filing indicate an open-market sale of shares by the CFO?

No. The filing explicitly describes the disposition as a net settlement by the issuer to satisfy tax withholding on vested RSUs, not an open-market sale.